Jonah Comstock

An older woman using telemedicine.

Photo by Getty

By Jonah Comstock 01:14 pmMarch 15, 2019
Intermountain Healthcare will expand its longtime Homecare & Hospice program into a new technology-supported initiative called Intermountain at Home, the health system announced last week. Intermountain at Home will use telemedicine and remote monitoring along with homecare visits to expand the program from palliative care and dialysis, which the system already offers at home, to include home...
By Jonah Comstock 03:08 pmMarch 14, 2019
Virta Health, the company that controversially claims to reverse Type 2 diabetes using a combination of diet and digitally-powered management efforts, has hired a big name in the digital health space as its new head of commercial: Derek Newell, who served as CEO of Jiff prior to its acquisition by Castlight. Newell stayed on with Castlight as president for a little over a year, according to his...

A HaptX glove.

By Jonah Comstock 01:44 pmMarch 14, 2019
Two virtual reality companies focused on surgery, Osso VR and FundamentalVR, announced major partnerships this week at the American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas. Palo Alto, California-based Osso VR announced a partnership with medical device technology company Smith & Nephew. Osso VR will build a custom training module Smith & Nephew’s NAVIO Surgical System...
By Jonah Comstock 03:13 pmMarch 13, 2019
  Correction: A brief originally included in this roundup, about Quip's funding, has been removed. The round in question was not new; it was previously reported here. ... With new investor, Klara heading to market. New York-based Klara, a healthcare messaging system, has secured a new investment from Stage 2 Capital. The amount of the investment was not disclosed. Klara brought Stage 2 in to help...
By Jonah Comstock 01:59 pmMarch 13, 2019
OOVA, a Mount Sinai Health System spinoff focused on fertility and women’s health, has raised $1 million in a seed round led by Special Situations Life Sciences Innovation Fund, with additional contributions from Company Ventures and angel investors. This is the first funding round for the company, not counting an initial friends and family investment. What they do The company’s first product,...

Photo by Justin Sullivan (Getty Images)

By Jonah Comstock 02:36 pmMarch 12, 2019
Blue Shield of California has tapped Teladoc to assist with a $2 million relief effort for Paradise, California, the small town that was ravaged last year by fires. The fire destroyed the largest clinic of Paradise Medical Group, one of the town’s major hospitals. Blue Shield has helped the hospital in a number of ways, including assisting with its relocation to a new space in Chico, California....
By Jonah Comstock 09:01 amMarch 12, 2019
San Francisco-based digital chronic disease managment company Omada Health announced today that it will add fully integrated, cellular-connected glucometers and blood pressure cuffs to its offerings for Type 2 diabetes and hypertension, respectively. The devices are FDA-cleared and can be mailed to program members. The glucometer will come with as many free test strips as users need, the company...
By Jonah Comstock 08:15 amMarch 12, 2019
BACtrack, a company that has been invested in the smartphone-connected breathalyzer for years now, has launched BACTrack View, a new remote monitoring service that will let friends, family, or sponsors check in remotely on a BACtrack user’s sobriety level. “Alcohol is a drug, and when people have addiction issues with drugs, when they’re at their worst, there can be a lot of lies and a lot of...
By Jonah Comstock 02:48 pmMarch 11, 2019
Belfast-based B-Secur has raised €4.7m (£4m) in Series A funding from existing investors Accelerated Digital Ventures and Kernel Capital. This brings their total funding to €11.7m (£10m). What they do B-Secur, whose HeartKey algorithms made a splash this year at CES, is looking to use ECG monitoring in a dual role: both for health and wellness purposes and for biometric identification. The...
By Jonah Comstock 01:26 pmMarch 11, 2019
At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not purport to diagnose a condition, is designed to help people understand when they’re at a higher-than-normal risk for Type 2 diabetes so they can alter their lifestyle. To assist with the latter piece,...